Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.
Paste Magazine is your source for the best music, movies, TV, comedy, videogames, books, comics, craft beer, politics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback